Clinical Scorecard: The mylovia Digital Intervention Enhances Sexual Function in Women with Dysfunction: Results from a Randomized Controlled Trial
At a Glance
Category
Detail
Condition
Female sexual dysfunction including hypoactive sexual desire, sexual arousal dysfunction, orgasmic dysfunction, and sexual pain-penetration disorder
Key Mechanisms
Mindfulness-based sex therapy (MBST) combined with cognitive-behavioral therapy (CBT) principles focusing on female sexual pleasure
Target Population
Women with clinically relevant sexual dysfunction or sexual pain-penetration disorder
Care Setting
Outpatient and primary care settings with digital therapeutic intervention accessible via prescription
Key Highlights
Female sexual dysfunction is common and often untreated due to stigma, lack of clinical training, and systemic gender bias.
Digital interventions like mylovia offer scalable, discreet, and accessible treatment options grounded in evidence-based MBST and CBT.
The randomized controlled trial showed that mylovia plus treatment as usual improves sexual functioning more than treatment as usual plus information alone.
Guideline-Based Recommendations
Diagnosis
Sexual problems must occur frequently over several months and cause clinically relevant distress to meet ICD-11 criteria.
Comprehensive assessment should consider biopsychosocial factors beyond isolated symptoms.
Management
Adopt a biopsychosocial model including psychological and mindfulness interventions.
Use CBT-based approaches incorporating psychoeducation, body awareness, mindfulness, self-exploration, sensuality exercises, and sexual communication techniques.
Consider digital therapeutics like mylovia as adjuncts to treatment as usual.
Monitoring & Follow-up
Evaluate sexual functioning improvements using validated measures during and after intervention.
Monitor patient engagement and adherence to digital therapeutic modules.
Risks
Potential under-treatment due to stigma and lack of provider training.
Heteronormative biases may limit comprehensive care and patient satisfaction.
Patient & Prescribing Data
Women diagnosed with female sexual dysfunction or sexual pain-penetration disorder in Germany
mylovia is a digital health application approved by German regulatory authorities and covered by statutory health insurance, enabling physician and psychotherapist prescription similar to medication.
Clinical Best Practices
Address female sexual dysfunction proactively in clinical settings to reduce stigma and treatment gaps.
Incorporate biopsychosocial and gender-sensitive frameworks in assessment and treatment planning.
Utilize evidence-based digital interventions to enhance accessibility and patient autonomy.
Provide training for healthcare providers on female sexual health and therapeutic options.
Focus treatment goals on sexual desire, pleasure, and personal agency rather than solely reproductive or penetrative functions.
